Nordwest Clinic (Krankenhaus)
Nordwest Clinic (Krankenhaus)
Niemcy, Frankfurt nad Menem
Elke Jaeger
41 lat doświadczenia
Akredytacje :
Colon cancer stage 4 treatment cost in Germany generally involves a complex oncology diagnostic running from $1,600 to $2,800 to determine the exact spread of the disease. Primary surgical interventions such as a colectomy (large bowel resection) typically run from $20,000 to $40,000, while advanced options like HIPEC range from $34,800 to $54,600. Total expenses depend on the combination of systemic therapies and robotic-assisted surgeries. Patients often save 30-54% compared to the United States. Top treatment destinations include Hamburg, Frankfurt am Main, and Solingen.
Typical Colon Cancer Stage 4 Treatment Costs in Germany
Bookimed Expert Insight: For advanced cases, multidisciplinary care at university-affiliated centers provides the best value. Nordwest Clinic (Krankenhaus) is ideal for patients seeking innovative targeted therapies and anticancer vaccines. Professor Thomas W. Kraus offers extensive surgical expertise with over 3,000 procedures performed. Patients requiring specialized palliative care should consider Asklepios Nord Clinic. Solingen Medical Center is a top-rated choice for German Cancer Society-certified oncology protocols.
| Niemcy | Turcja | Austria | |
| Kolektomia (resekcja jelita grubego) | od $20,000 | od $6,912 | od $22,000 |
| Hipec (Hipertermiczna Chemioterapia Dootrzewnowa) | od $34,822 | od $22,500 | od $40,000 |
| Chemioterapia w raku piersi | od $4,500 | od $1,200 | od $15,000 |
Akademicka Klinika Solingen — wielospecjalistyczny szpital w Niemczech, w TOP najlepszych szpitali w kraju według magazynu Focus.
Specjalizacja — onkologia, neurochirurgia, gastroenterologia, kardiologia i ortopedia.
2 lekarzy kliniki znajduje się na liście polecanych specjalistów w Niemczech według Focus i Guter Rat— profesor Wolfgang Schwenk, chirurg jamy brzusznej, oraz profesor Peter Hering, specjalista w leczeniu nadciśnienia i chorób nerek.
Rocznie do Solingen zgłasza się ponad 60 000 pacjentów.
Prof. Elke Jaeger jest czołową specjalistką w dziedzinie mięsaków w klinice Nordwest, uznawaną za jednego z najlepszych onkologów w Niemczech według rankingu Focus.
Przeprowadził ponad 3000 skomplikowanych interwencji chirurgicznych — profesor Kraus jest uznanym w kraju specjalistą w zakresie chirurgii trzustki w Klinice Nordwest.
Germany offers innovative Stage 4 colon cancer treatments through multi-modal strategies. These include hyperthermic intraperitoneal chemotherapy (HIPEC) for abdominal spread and personalized immunotherapy vaccines. Specialized centers utilize molecular diagnostics to target specific genetic mutations within the liver and lungs.
Bookimed Expert Insight: German oncology centers like Nordwest Clinic and Bremen-Mitte emphasize multidisciplinary tumor boards. These boards include surgeons like Prof. Thomas W Kraus and oncologists like Prof. Elke Jaeger. Our data shows this collaboration often makes borderline resectable cases operable. Patients seeking advanced local control should look for centers with integrated interventional radiology departments. These facilities provide localized tumor destruction while sparing healthy tissue.
Patient Consensus: Patients emphasize the need for broad molecular profiling to find personalized drug matches. They suggest checking if metastases are resectable before starting systemic treatment alone.
Immunotherapy is not a universal treatment for stage 4 colon cancer in Germany. It is prescribed for approximately 5% of patients with specific genetic biomarkers. These include High Microsatellite Instability or Mismatch Repair Deficiency. For the remaining 95%, chemotherapy and targeted therapies remain the primary medical protocols.
Bookimed Expert Insight: While many search for immunotherapy, the focus in Germany is shifting toward high-volume surgical expertise. Prof. Thomas W Kraus at Nordwest Clinic has performed over 3,000 procedures. Clinics like Nordrhein-Westfalen serve 145,000 patients annually. This volume suggests that specialized surgery remains a cornerstone of German care alongside drug therapies.
Patient Consensus: Patients note that molecular profiling is the most important step for accessing immunotherapy. It is essential to push for these tests early during the diagnostic phase.
German university centers and DKG-certified clinics like Nordwest Clinic and Medical Center Solingen are global leaders for Stage 4 colon cancer. These facilities utilize molecular tumor boards and advanced surgical techniques. Specialists like Prof. Dr. Thomas W. Kraus perform thousands of complex liver resections for metastatic cases.
Bookimed Expert Insight: German clinics like Nordwest Clinic and Nordrhein-Westfalen Clinic Complex handle massive patient volumes, reaching 145,000 annually. This high frequency correlates with lower risk during complex HIPEC or liver resections. Hospitals in the North Rhine-Westphalia region, such as Lippe Lemgo, often lead Focus magazine rankings. Patients seeking second opinions should target these regional hubs first for the most experienced tumor boards.
Patient Consensus: Patients note it's important to find centers that evaluate the primary tumor and metastases together. Many emphasize having specialized liver metastasis surgeons available in-house for a truly multimodal treatment plan.
Clinical trials for advanced colorectal cancer are widely accessible in Germany. These studies offer innovative treatments like mRNA vaccines and specialized immunotherapy. Leading research centers such as Nordwest Clinic are certified by the German Cancer Society. Eligibility depends on biomarkers like KRAS or BRAF mutations.
Bookimed Expert Insight: Data shows that choosing a clinic like Nordwest Clinic (Krankenhaus) provides a significant advantage. It houses five separate research institutes. This structure allows patients faster access to immunotherapy trials than standard regional hospitals. Prof. Dr. Thomas W Kraus has performed over 3,000 surgeries. His expertise helps bridge the gap between complex resection and experimental protocol eligibility.
Patient Consensus: Patients note that biomarker testing is a critical gatekeeper for trial entry. They recommend requesting a direct referral to a university hospital to bypass more limited local treatment options.